This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business class action lawsuit

Rosen Law Firm sues Medpace

Analysis based on 74 articles · First reported Apr 08, 2026 · Last updated Jun 08, 2026

Sentiment
-30
Attention
4
Articles
74
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The market is impacted by the potential financial liabilities for Medpace due to the class action lawsuit, which could lead to a decrease in its stock price. Investors who purchased Medpace stock during the Class Period may be entitled to compensation, affecting their investment returns.

pharmaceuticals legal services

Rosen Law Firm is actively encouraging investors to join a class action lawsuit against Medpace Holdings, Inc. The lawsuit alleges that Medpace made false and misleading statements and concealed material adverse facts concerning its backlog cancellation rate between April 22, 2025, and February 9, 2026. Medpace reportedly touted 'well behaved' cancellation rates and provided overly positive growth expectations, specifically a 1.15 book-to-bill ratio, which the lawsuit claims could not be maintained. Investors who purchased Medpace common stock during this period are encouraged to secure counsel before the June 8, 2026, lead plaintiff deadline. Philip Kim and Lawrence Rosen of Rosen Law Firm are key contacts for this action.

stock
Medpace is the defendant in a class action lawsuit alleging that it made false and misleading statements regarding its backlog cancellation rates, leading to investor damages.
Importance 100.0 Sentiment -40.0
priv
Bronstein, Gewirtz & Grossman, LLC is the law firm that filed the class action lawsuit against Medpace, representing investors and seeking to recover damages.
Importance 90.0 Sentiment 60.0
priv
Rosen Law Firm is initiating and encouraging investors to join a class action lawsuit against Medpace, seeking compensation for alleged investor damages.
Importance 90.0 Sentiment 20.0
priv
Faruqi & Faruqi is a national securities law firm investigating potential claims against Medpace and reminding investors of the deadline to seek lead plaintiff status in the class action lawsuit.
Importance 80.0 Sentiment 50.0
priv
The Schall Law Firm is representing investors in a class action lawsuit against Medpace, encouraging shareholders to join the case to recover losses.
Importance 80.0 Sentiment 20.0
per
Philip Kim is an attorney at Rosen Law Firm and is a contact person for investors interested in joining the Medpace class action lawsuit.
Importance 70.0 Sentiment 10.0
priv
Robbins Geller Rudman & Dowd LLP is another law firm that has announced a class action lawsuit against Medpace and is seeking lead plaintiffs.
Importance 70.0 Sentiment 35.0
per
Lawrence Rosen is a founding partner of Rosen Law Firm, which is leading the class action lawsuit against Medpace.
Importance 60.0 Sentiment 10.0
per
Brian Schall is an attorney at The Schall Law Firm, encouraging investors to contact him regarding the class action lawsuit against Medpace.
Importance 60.0 Sentiment 10.0
per
Ken Dolitsky, an attorney at Robbins Geller Rudman & Dowd LLP, is a contact for investors regarding the Medpace class action lawsuit.
Importance 50.0 Sentiment 30.0
per
Michael Albert, an attorney at Robbins Geller Rudman & Dowd LLP, is a contact for investors regarding the Medpace class action lawsuit.
Importance 50.0 Sentiment 30.0
per
Peretz Bronstein is a founding partner of Bronstein, Gewirtz & Grossman, LLC, and is involved in the class action lawsuit against Medpace.
Importance 40.0 Sentiment 50.0
per
James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in Medpace to contact him to discuss their legal options.
Importance 30.0 Sentiment 40.0
govactor
The United States — United States Securities and Exchange Commission's rules and acts are cited as the basis for the class action lawsuit against Medpace.
Importance 30.0 Sentiment 0.0
per
Nathan Miller is a Client Relations Manager at Bronstein, Gewirtz & Grossman, LLC, and is a contact for investors regarding the Medpace class action lawsuit.
Importance 20.0 Sentiment 30.0
+ 2 more entities View on Dashboard
Medpace related Rosen Law Firm
Medpace related Philip Kim
Medpace related Lawrence Rosen
Bronstein, Gewirtz & Grossman, LLC competitor Rosen Law Firm Bronstein, Gewirtz & Grossman, LLC is a direct competitor to Rosen Law Firm in the plaintiff-side securities class actio
Bronstein, Gewirtz & Grossman, LLC competitor Faruqi & Faruqi Bronstein, Gewirtz & Grossman, LLC is a securities litigation law firm that directly competes with Faruqi & Faruqi to re
Bronstein, Gewirtz & Grossman, LLC competitor The Schall Law Firm Bronstein, Gewirtz & Grossman, LLC is a shareholder rights litigation firm that directly competes with The Schall Law Fi
Rosen Law Firm competitor Faruqi & Faruqi Rosen Law Firm competes directly against Faruqi & Faruqi in the securities litigation space, as both firms regularly sol
Rosen Law Firm competitor The Schall Law Firm Rosen Law Firm operates as a direct competitor to The Schall Law Firm, with both practices frequently competing to repre
+ 24 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.